Patients and intervention method
-20
Eligible participants encompassed both women and men aged over 18, with a body mass index between 18 kg/mInclusion and exclusion criteria for patients.The administration of treatment occurred via nebulization utilizing a NEBUCOR compressor (P-103 model). Patients inhaled a solution consisting of 1 mL of the drug mixed with 4 mL of 0.9% saline solution (groups A and B), or 5ml of 0.9% saline solution as specified (control group), for a duration of 18-20 minutes, repeated every 24 hours over a span of 15 consecutive days.